PATENT CLAIM ANALYSIS

Application Number: 16125290
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2018-12
Patent Classification: ["514", "422000"]

Abstract:
The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.

Claim (Index 21):
The method of  claim 12 , wherein the cancer is penile cancer.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.78571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15231684', '14356979', '16058411', '15701872', '15601278']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.742543347108263
- 35 USC 102 Novelty (BERT): 0.5594313218350513
- Combined Prediction Score: 0.7242321445809418
- Mean Citation Score: 285.3860200000001
- Max Citation Score: 429.46732
- Similarity Product: 298.1844061554861

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test